Celator Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351
November 18, 2008 by admin
 | We comply with the HONcode standard for trustworthy health information: verify here. |
Featured Video
Categories
- Medical News
- Cancer Treatment
- Breast Cancer
- Cervical - Endometrial - Ovarian - Uterine - Womb Cance
- Prostate & Testicular Cancers
- Esophageal, Oral, Tongue, Throat, Neck, Head Cancers
- Colon - Rectal - Corectal Cancers
- Melanoma - Skin Cancer
- Stomach & Gastric Cancer
- Lung Cancer
- Hodgkins & Non-Hodgkins Lymphoma
- Bladder Cancer
- Liver Cancer
- Pancreatic Cancer
- FDA NEWS DIGEST
- Brain News & Ailments
- Breakthrough Digest Medical News
- Viral & Infection News
- Heart Disease
- Stem Cell Research
- Alzheimers - Dementia
- Genetics - Gene Therapy
- Diabetes
- AIDS - HIV
- Tumors
- Women's Health
- Vaccines
- Gastrointestinal - IBD
- Arthritis, Gout, & Joint Disease
- Eye Ailments
- Obesity
- Parkinson Disease
- Leukemia
- lung News & Ailments
- Stroke
- Hepatitis
- Multiple Sclerosis (MS)
- Nanotechnology
- Muscular Dystrophy
- Huntington
- Spinal Injuries
- Autism
- Schizophrenia
- Depression
- Liver Ailments
- Kidney Ailments
- Lou Gehrig Disease (ALS)
- Malaria
- Hypertension
- Aging
Comments